INDI-NO-GO: A Recommendation for Caution with Use of Isocitrate Dehydrogenase Inhibitors for High-Risk, Low-Grade Gliomas. Singh R, Palmer JD. Int J Radiat Oncol Biol Phys 2025;122:223.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singh R, Palmer JD. INDI-NO-GO: A Recommendation for Caution with Use of Isocitrate Dehydrogenase Inhibitors for High-Risk, Low-Grade Gliomas. Int J Radiat Oncol Biol Phys 2025;122:223.
PMID: 40382163